Read a panel discussion with 5 national experts discussing the clinical care of patients with concussion and which biomarkers are the most promising candidates for evaluating concussed patients
Donald W. Marion, MD, MSc
Jeffrey J. Bazarian, MD, MPH
Jessica Gill, RN, FAAN, PhD
Geoffrey Manley, MD, PhD
Michael A. McCrea, PhD, ABPP
Ava M. Puccio, RN, PhD
Watch a replay of the Expert Theater from ACEP (American College of Emergency Physicians) 2020 conference. Dr. Jesse Pines, National Director of Clinical Innovation U.S. Acute Care Solutions and Professor of Emergency Medicine at Drexel University, presents effective strategies and trends related to head injury evaluation. The presentation is followed by Dr. Frank Peacock, Vice Chair for Emergency Medicine Research at Baylor College of Medicine, who discusses the latest research on the potential of biomarkers to aid in the evaluation of brain injury patients.
Learn how researchers are developing objective methods to assess patients with suspected mTBI. Watch how biomarkers may be used in the future to address limitations associated with existing assessment tools to help doctors objectively assess brain injuries. Measuring biomarker levels may have the potential to improve ED performance by evaluating patients faster, reducing unnecessary CTs and reducing patient length of stays, and ensuring patients get more appropriate care.
Worldwide each year, 50 million+ people sustain a traumatic brain injury (TBI). Symptoms resolve quickly for many patients, while others can take several weeks to months for post-concussive symptoms to resolve, and yet another subset of patients continue to experience persistent symptoms for 3 months or more after injury. Hear from leading experts about effective strategies and trends related to head injury evaluation and an update regarding potential advances in biomarker research.
PACE® credit will be provided for this session.
December 7th session
Dr. Watanabe is Clinical Director of the Drucker Brain Injury Center at MossRehab, director of the MossRehab Stroke program and Associate Professor in the Department of Physical Medicine and Rehabilitation at the Temple University School of Medicine in Philadelphia. He is a co-investigator on the current Traumatic Brain Injury Model System grant supported by the NIDILRR and has participated in several other clinical trials related to recovery after stroke and brain injury. He has authored or co-authored several peer-reviewed articles related to the treatment of individuals with acquired brain injuries.
Dr. Jones is a Consultant in Emergency Medicine at the Bradford Teaching Hospitals Foundation Trust and leads the Bradford Royal Infirmary Acute Musculoskeletal Clinic. Dr. Jones is also involved in Sports and Exercise Medicine and formerly held the post of Head of Medical Services where he oversaw the medical departments of both Leeds Rhinos Rugby League and Yorkshire Carnegie Rugby Union. He is currently the course director for the Rugby Football Unions Pre-Hospital Immediate Care in Sport Course and part of the Twickenham Stadium international match day medical team.
Worldwide each year, 50 million+ people sustain a traumatic brain injury (TBI); most cases are mild with variable clinical outcomes and lasting symptoms.1 Hear from leading experts about effective strategies and trends related to brain injury evaluation. The latest blood-based biomarker research and their potential to predict the absence of intracranial injury will also be presented.
These webinars will discuss how biomarkers may be used in the future clinically to improve patient care in the hospital and outpatient setting. It will also identify the role of brain biomarkers in the hospital's performance.
Jeff Bazarian is Professor of Emergency Medicine and Neurology at the University of Rochester.
Robert D. Welch is Professor, Clinical Educator, in the Department of Emergency Medicine and is the Director of the Biostatistics and Epidemiology Research Design Group.
1. Nelson LD, Temkin NR, Dikmen S, et al. Recovery after mild traumatic brain injury in patients presenting to US level I trauma centers. JAMA Neurol.2019;76(9):1049.